Our faculty author, co-author and contribute to more than 1500 peer-reviewed scientific publications each year. Find their recent publications below, and filter by division.
Search the faculty directory to find an individual's list of publications.
Publications
Ge, Jie, Hongliang Liu, Danwen Qian, Xiaomeng Wang, Patricia G. Moorman, Sheng Luo, Shelley Hwang, and Qingyi Wei. “Genetic variants of genes in the NER pathway associated with risk of breast cancer: A large-scale analysis of 14 published GWAS datasets in the DRIVE study..” Int J Cancer 145, no. 5 (September 1, 2019): 1270–79. https://doi.org/10.1002/ijc.32371.
PMID
31026346
Randazzo, D. M., F. McSherry, J. E. Herndon, M. L. Affronti, E. S. Lipp, C. Flahiff, E. Miller, et al. “Complementary and integrative health interventions and their association with health-related quality of life in the primary brain tumor population.” Complementary Therapies in Clinical Practice 36 (August 1, 2019): 43–48. https://doi.org/10.1016/j.ctcp.2019.05.002.
Chen, Ka, Hongliang Liu, Zhensheng Liu, Sheng Luo, Edward F. Patz, Patricia G. Moorman, Li Su, Sipeng Shen, David C. Christiani, and Qingyi Wei. “Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients..” Int J Cancer 145, no. 3 (August 1, 2019): 621–31. https://doi.org/10.1002/ijc.32128.
PMID
30650190
Sun, Yuanyuan, Suya Wang, Hainan Yang, Jiangping Wu, Sha Li, Guoliang Qiao, Shuo Wang, et al. “Impact of synchronized anti-PD-1 with Ad-CEA vaccination on inhibition of colon cancer growth..” Immunotherapy 11, no. 11 (August 2019): 953–66. https://doi.org/10.2217/imt-2019-0055.
PMID
31192764
Xu, Xinyuan, Danwen Qian, Hongliang Liu, Diana Cruz, Sheng Luo, Kyle M. Walsh, James L. Abbruzzese, Xuefeng Zhang, and Qingyi Wei. “Genetic variants in the liver kinase B1-AMP-activated protein kinase pathway genes and pancreatic cancer risk..” Mol Carcinog 58, no. 8 (August 2019): 1338–48. https://doi.org/10.1002/mc.23018.
PMID
30997723
Innocenti, Federico, Chen Jiang, Alexander B. Sibley, Stefanie Denning, Amy S. Etheridge, Dorothy Watson, Donna Niedzwiecki, et al. “An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance)..” Pharmacogenet Genomics 29, no. 6 (August 2019): 123–31. https://doi.org/10.1097/FPC.0000000000000375.
PMID
30889042
Luo, Xiaoning, Erich M. Sturgis, Zheng Yang, Yan Sun, Peng Wei, Zhensheng Liu, Qingyi Wei, and Guojun Li. “Lymphocyte telomere length predicts clinical outcomes of HPV-positive oropharyngeal cancer patients after definitive radiotherapy..” Carcinogenesis 40, no. 6 (July 6, 2019): 735–41. https://doi.org/10.1093/carcin/bgz019.
PMID
30721961
Tucker, Matthew D., Jason Zhu, Daniele Marin, Rajan T. Gupta, Santosh Gupta, William R. Berry, Sundhar Ramalingam, et al. “Pembrolizumab in men with heavily treated metastatic castrate-resistant prostate cancer..” Cancer Med, July 3, 2019. https://doi.org/10.1002/cam4.2375.
PMID
31270961
Sambade, Maria J., Grace Prince, Allison M. Deal, Dimitri Trembath, Megan McKee, Amy Garrett, Kevin Keith, et al. “Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases..” Breast Cancer Res Treat 176, no. 2 (July 2019): 321–28. https://doi.org/10.1007/s10549-019-05211-1.
PMID
31016641
Bellon, Jennifer R., Hao Guo, William T. Barry, Chau T. Dang, Denise A. Yardley, Beverly Moy, P Kelly Marcom, et al. “Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)..” Breast Cancer Res Treat 176, no. 2 (July 2019): 303–10. https://doi.org/10.1007/s10549-019-05238-4.
PMID
31004299